Apyx Medical Corporation
APYX
$3.63
-$0.06-1.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 52.22% | 48.88% | 39.16% | 12.14% | -25.38% |
| Total Depreciation and Amortization | 9.35% | -5.42% | -14.59% | -10.22% | -13.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.61% | -47.49% | -45.64% | -27.01% | -16.14% |
| Change in Net Operating Assets | -27.79% | -44.86% | -75.17% | -67.21% | -122.46% |
| Cash from Operations | 55.67% | 51.46% | -1.37% | -27.80% | -243.82% |
| Capital Expenditure | -54.29% | -90.18% | -21.49% | -62.01% | -35.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -54.29% | -90.18% | -21.49% | -110.90% | -110.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 99.83% | 99.82% | 99.82% | 99.82% |
| Issuance of Common Stock | 39.83% | -- | 23,233.33% | 8,039.53% | 8,039.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.00% | -125.22% | -120.81% | -124.38% | 28.13% |
| Cash from Financing | 42.03% | -71.23% | -71.64% | -71.83% | -79.03% |
| Foreign Exchange rate Adjustments | -512.39% | -315.52% | -590.91% | 185.25% | 159.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.99% | -148.95% | -123.78% | -129.82% | -135.60% |